4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-18-021234
Chief Financial Officer sold 120 shares at $8.25 ($990)
- Chief Financial Officer acquired 120 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BLOCH KATHLEEN P. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-04-17 | Exercise or conversion : show line 1 in the form | +120 | $4.69 | $563 | 253,424 | D |
| 2018-04-17 | Sale : show line 2 in the form | −120 | $8.25 | $990 | 253,304 | D |
| Open-market sales · 120 sh · avg $8.25 · $990 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-04-17 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −120 | 24,800 | D |
Loading xslF345X03/tv491396_4.xml…